Hercules Capital, Inc. (HTGC) News
Filter HTGC News Items
HTGC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HTGC News Highlights
- For HTGC, its 30 day story count is now at 5.
- Over the past 8 days, the trend for HTGC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- LOAN, DEC and ENGN are the most mentioned tickers in articles about HTGC.
Latest HTGC News From Around the Web
Below are the latest news stories about HERCULES CAPITAL INC that investors may wish to consider to help them evaluate HTGC as an investment opportunity.
Hercules Capital (HTGC) Outperforms Broader Market: What You Need to KnowIn the latest trading session, Hercules Capital (HTGC) closed at $16.41, marking a +0.98% move from the previous day. |
enGene Announces Expanded $50 Million Debt Facility with Hercules CapitalenGene Holdings Inc. ("enGene," Nasdaq: ENGN), a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), announced today that it has entered into an amended USD $50 million loan agreement (the "Loan Agreement") with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). Under the Loan Agreement, which has a term of four years, $22.5 million has been advanced to enGene under a non-revolving term loan and, |
Investors in Hercules Capital (NYSE:HTGC) have seen splendid returns of 155% over the past five yearsWhen you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore... |
This Dividend Stock Has Returned 157% Over the Past 10 Years. You Can Buy It Today for Just $15Hercules Technology Growth Capital makes high-yield loans to energy, life sciences, and technology businesses. |
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules CapitalAmendment provides more favorable terms including a 14-month extension of the interest-only period and maturity date until December 2027Up to an additional $100 million in non-dilutive capital available subject to the achievement of certain revenue milestonesCash runway now expected through the end of 2026 FLORHAM PARK, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for g |
Rise in Customized Financing Aids Hercules Capital (HTGC)Hercules Capital's (HTGC) top line is expected to keep improving, driven by the growing demand for customized financing. |
12 Very High Yield Dividend Stocks With Upside PotentialIn this article, we discuss 12 very high yield dividend stocks with upside potential. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Very High Yield Dividend Stocks With Upside Potential. Many investors are drawn to dividend investing for various reasons, but among […] |
Are Finance Stocks Lagging Hercules Capital (HTGC) This Year?Here is how Hercules Capital (HTGC) and Assured Guaranty (AGO) have performed compared to their sector so far this year. |
Hercules Capital Receives SBA "Green Light" Letter to Submit Its Fourth SBIC License ApplicationPALO ALTO, Calif., November 09, 2023--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that the U.S. Small Business Administration ("SBA") has issued a "green light" letter inviting Hercules to submit an application to obtain a license to form and operate a f |
Hercules Capital Announces Upcoming Events for the Financial CommunityPALO ALTO, Calif., November 08, 2023--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that members of the executive management team will be participating at the following events for the financial community: |